Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurobiological Tech (NTII) -- Ignore unavailable to you. Want to Upgrade?

To: JMarcus who wrote (376)	11/12/1998 10:47:00 PM
From: VikingWarrior	Respond to of 1494

Thank you very much for posting your summary of the shareholders meeting. Your thoroughness and attention to detail conveyed not only the substance but some of the feeling that was evidently expressed. Thanks again. Dave Martinson

To: JMarcus who wrote (376)	11/13/1998 5:27:00 AM
From: BRAVEHEART	Read Replies (2) \| Respond to of 1494

Hi J Marcus, I too appreciate your highly detailed and informative post. I was wondering if by year end 1999 you mean fiscal year end June 30th 1999 or annual year end Dec 30th 1999. I also appreciate your posting at the Viragen website as there is some interest there for NTI as an investment. Was there much more said on the role of the PR firm? Let's face it there has to be more to it than just getting press releases out. I am curious as to the potential anticipated benefit of hiring such a firm. I am familiar with the firm somewhat. A high level broker whom I had contact with was responsible for pressuring another organization to hire Russel Welch for similar services. The end result was it did indeed help move the stock considerably. That company had 50 plus million shares outstanding. I can only speculate what benefits it will have for us as long term shareholders and for the companies interests. That speculation is it will be good in the end. I would imagine that by the end of December one of two potential scenarios will play out. Either the share price will be enhanced through PR efforts and a suitor for a bridge loan will be convinced to loan the company the needed monies resulting in 2+ million added shares. Or a similar inhouse financing or somewhat more dilutive offering will be accomplished at the existing shareprice adding potentially 3+ million more shares to the bottom line. Either of the two events would be considered necessary evils. Let's face it such dilution would be small relative to the companies potential and existing number of shares. We as shareholders have to realize that to see the potential of this organization realized it will require added funds in this manner. The interests of some sort of institutional investor could do wonders for the stocks visibility. Especially if it is somehow associated with a high level brokerage house. I too have confidence in Paul Freimans judgment in these matters. Realize that insiders just recently shelled out $500,000 for additional shares in the company with this plan in mind. Hence my guess is this will unfold to all our benefit and makes the existing shareprice a relative safe entry point from all angles. Again J Marcus your post are much appreciated. Jeffrey

To: JMarcus who wrote (376)	11/13/1998 10:34:00 AM
From: Dr. John M. de Castro	Respond to of 1494

J. Marcus - Thank you for the excellent report. I have to admit being disappointed at the Xerecept news. But, the rest is dynamite. I also have to tip my cap to Freiman for saving this company and at the same time not diluting shareholder value. He deserves all the praise and kudos that we investors can give a CEO. John de C

To: JMarcus who wrote (376)	11/13/1998 5:03:00 PM
From: Dr. John M. de Castro	Read Replies (2) \| Respond to of 1494

"Freiman said that he is in advanced stages of negotiating a marketing partnership with at least four different companies." This is great news. If there is that much interest then Freiman can negotiate from a position of strength and obtain excellent terms. He doesn't appear to be a short term thinker. So, I'd guess that he'd be looking for a large royalty rate in preference to a large up-front payment. Were any hints provided as to who were the companies? John de C